Clinical Trial Update: Inclisiran Effectiveness in China: a Pragmatic Randomized Trial [Phase 4]

View source ↗

Summary

Phase 4 pragmatic randomized trial updating on inclisiran's effectiveness for coronary heart disease in China; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• Inclisiran (inclisiran)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Coronary Heart Disease | Phase 4 | Status: ACTIVE_NOT_RECRUITING